Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy market size is expected to reach $2.47 billion by 2029 at 7.9%, segmented as by product type, glassia, aralast np, prolastin c, zemaira and respreeza
Read More
Global Alopecia market size is expected to reach $13.88 billion by 2029 at 4.6%, segmented as by alopecia areata, patchy alopecia areata, persistent patchy alopecia areata, alopecia universalis, diffuse alopecia areata, ophiasis
Read More
Global Allergic Rhinitis market size is expected to reach $18.49 billion by 2029 at 4.1%, segmented as by seasonal allergic rhinitis, pollen allergy, mold allergy
Read More
Global AI-Enabled Medical Imaging Solutions market size is expected to reach $8.68 billion by 2029 at 31.4%, segmented as by software, image analysis and interpretation software, workflow and management solutions, diagnostic support tools
Read More
Global AI-Based Clinical Trial Solution Providers market size is expected to reach $6.96 billion by 2029 at 23%, segmented as by phase-i, safety and dosage studies, early pharmacokinetics studies
Read More
Global AI In Patient Engagement market size is expected to reach $20.6 billion by 2029 at 21.8%, segmented as by chatbots, virtual health assistants, appointment scheduling bots, symptom checkers
Read More
Global AI In Oncology For Analytical Solutions market size is expected to reach $4.66 billion by 2029 at 34.1%, segmented as by data licensing services, oncology data licensing, genomic data licensing
Read More
Global AI in Mental Health market size is expected to reach $6.68 billion by 2029 at 34.9%, segmented as by software-as-a-service (saas), ai-powered chatbots, virtual therapy platforms, mental health assessment tools, predictive analytics solutions
Read More
Global AI In Cancer Diagnostics market size is expected to reach $1.64 billion by 2029 at 19.9%, segmented as by software solutions, machine learning software, deep learning software, image analysis software
Read More
Global Adult Malignant Glioma Therapeutics market size is expected to reach $3.55 billion by 2029 at 9.4%, segmented as by glioblastoma multiforme, standard treatments, experimental therapies
Read More